Brief: Bioinvent Presents Data Providing Evidence Of The Potential Of Anti-Tnfr2 Antibody Bi-1910

BioInvent International AB

31/10/2023 13:58

Oct 31 (Reuters) - BioInvent International AB  BINV.ST :
    * BIOINVENT PRESENTS PRECLINICAL DATA AT SITC PROVIDING
CLEAR
EVIDENCE OF THE POTENTIAL OF ANTI-TNFR2 ANTIBODY BI-1910
    * BROAD ANTI-TUMOR ACTIVITY IN PRECLINICAL STUDIES,
ACTIVATING T
CELLS AND NK CELLS
    * DATA SUPPORT START OF PHASE 1 TRIAL IN H2 2023, FURTHER
EXPANDING

Source text for Eikon:  ID:nMFN2HNFP1 
Further company coverage:  BINV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 58 769 66 00;))